During a live event, Pedro C. Barata, MD, MSc, discussed the case of a patient with advanced clear cell renal cell carcinoma who requires second-line therapy.

Credit: Getty Images Clinicians can use 4 key questions to initiate discussions about pelvic health, aiding in screening, and determining the need for pelvic health physical therapy or further ...

Sanofi has called time on breast cancer candidate amcenestrant – at one time one of its top pipeline prospects – after it missed the mark in another clinical trial. The decision to abandon ...

That study established the company’s Astellas-partnered Nectin-4 ADC Padcev and Merck & Co.’s PD-1 king Keytruda as the standard first-line bladder cancer treatment in a biomarker-unselective ...

On J&J's second-quarter results call, head of innovative medicine Jennifer Taubert said that there is a pressing need for new therapy in first-line NSCLC, with about a quarter of patients never ...

In nonsquamous NSCLC, novel agents, such as pemetrexed and bevacizumab, have improved survival in the first-line setting. Maintenance therapy with pemetrexed and erlotinib resulted in improved ...

When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to ...

Patients with MSI-H tumors who received immunotherapy as first-line treatment had significantly longer OS than those who received chemotherapy only (HR = 0.37; 95% CI, 0.25-0.56). Those with MSS ...

A robust treatment plan for COPD includes a combination ... Supplemental oxygen and pulmonary rehabilitation for COPD Most people with COPD first notice symptoms around the age of 40.

There’s no cure for Alzheimer’s disease, but treatments like medication, physical therapy, talk therapy ... main stages of Alzheimer’s. The first three stages are classified as pre-dementia ...

Thiazides are widely used as first-line therapy for hypertension. In patients with HF, the more potent loop diuretics are preferred. Furthermore, in HF patients with volume overload not responding ...

"We, once again, jointly witnessed a strong positive result of [disitamab vedotin] combined with toripalimab in the first-line treatment of advanced urothelial carcinoma. Regardless of whether the ...